|
⚲
|
| Keyboard |
| Mark Glickman | |
|---|---|
| Firm | |
| Address | 545 Concord Avenue Suite 210 Cambridge, MA 02138 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Metavia Inc | 021-546292 | Director | 10.0 M of 10.0 M |
||
| Neurobo Pharmaceuticals Inc | 021-517518 | Director | 17.0 M of 17.0 M |
||
| TherapeuticsMD Inc | 021-464765 | Executive Officer | 7.0 M of 7.0 M |
||
| TherapeuticsMD Inc | 021-462011 | Executive Officer | 7.0 M of 7.0 M |
||
| TherapeuticsMD Inc | 021-456038 | Executive Officer | 15.0 M of 15.0 M |
||
| Hancock Jaffe Laboratories Inc | 021-372469 | Executive Officer | 1.6 M of 1.6 M |
||
| Aralez Pharmaceuticals Inc | 021-257798 | Executive Officer | 75.0 M of 75.0 M |
||